Trial intelligence / Profile preview

Dapsone Gel for Dermatitis Herpetiformis

NCT01115244Phase 4Terminated

Sponsor
Vanderbilt University Medical Center
Start
Jul 2010
Primary completion
Mar 2012
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of dapsone in dermatitis herpetiformis (DH), sponsored by Vanderbilt University Medical Center. Started Jul 2010; status: terminated.

02

Drugs

dapsone
03

Conditions

dermatitis herpetiformis (DH)

Beyond the preview

Go deeper on NCT01115244.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01115244.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call